Capsule of Streptococcus pyogenes is essential for delayed death of mice in a model of streptococcal toxic shock syndrome

Microbiology and Immunology

Volumn 50, Issue 2, 2006, Pages 127-130

  Iida, Ken Ichiro ^a   Seki, Masanori ^a   Saito, Mitsumasa ^a   Kawamura, Yoshiaki ^b   Kajiwara, Hideko ^a   Yoshida, Shin Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Capsule; Severe group A streptococcal infection; Streptococcus pyogenes

Indexed keywords

HYALURONIC ACID; PROTEIN HASA; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; DEATH; DISEASE MODEL; EXPERIMENTAL INFECTION; FATALITY; GENE CONSTRUCT; HOMOLOGOUS RECOMBINATION; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; SURVIVAL; TOXIC SHOCK SYNDROME;

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PYOGENES;

EID: 33244488061     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03777.x     Document Type: Article

References (20)

1. Aoki, H., Shiroza, T., Hayakawa, M., Sato, S., and Kuramitsu, H.K. 1986. Cloning of a Streptococcus mutans glucosyltransferase gene coding for insoluble glucan synthesis. Infect. Immun. 53: 587-594.
2. Ashbaugh, C.D., Warren, H.B., Carey, V.J., and Wessels, M.R. 1998. Molecular analysis of the role of the group A streptococcal cystein protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J. Clin. Invest. 102: 550-560.
3. Chang, Y.C., and Kwon-Chung, K.J. 1994. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol. Cell. Biol. 14: 4912-4919.
4. Cunningham, M.W. 2000. Pathogenesis of group A streptococcal infection. Clin. Microbiol. Rev. 13: 470-511.
5. Hashikawa, S., Iinuma, Y., Furushita, M., Ohkura, T., Nada, T., Torii, K., Hasegawa, T., and Ohta, M. 2004. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J. Clin. Microbiol. 42: 186-192.
6. Kawabata, S., Kuwata, H., Nakagawa, I., Morimatsu, S., Sano, K., and Hamada, S. 1999. Capsular hyaluronic acid of group A Streptococci hampers their invasion into human pharyngeal epithelial cells. Microb. Pathog. 27: 71-80.
7. Magee, A.D., and Yother, J. 2001. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect. Immun. 69:3755-3761.
8. Moxon, E.R., and Vaughn, K.A. 1981. The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants. J. Infect. Dis. 143: 517-524.
9. Okamoto, S., Kawabata, S., Fujitaka, H., Uehara, T., Okuno, Y., and Hamada, S. 2004. Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection. Vaccine 22: 2887-2893.
10. Okamoto, S., Kawabata, S., Nakagawa, I., Okuno, Y., Goto, T., Sano, K., and Hamada, S. 2003. Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J. Virol. 77: 4104-4112.
11. Okamoto, S., Kawabata, S., Terao, Y., Fujitaka, H., Okuno, Y., and Hamada, S. 2004. The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection. Infect. Immun. 72: 6068-6075.
12. Saito, M., Kajiwara, H., Ishikawa, T., Iida, K., Endoh, M., Hara, T., and Yoshida, S. 2001. Delayed onset of systemic bacterial dissemination and subsequent death in mice injected intramuscularly with Streptococcus pyogenes strains. Microbiol. Immunol. 45: 777-786.
13. 2-nonproducing Steptococcus pyogenes strains: survival in stationary phase and virulence in chronic granulomatous disease. Microbiology 147: 2469-2477.
14. Schlievert, P.M., Gocke, J.E., and Deringer, J.R. 1993. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin. Infect. Dis. 17: 26-31.
15. Simon, D., and Ferretti, J.J. 1991. Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol. Lett. 66: 219-224.
16. Sriskandan, S., Unnikrishnan, M., Krausz, T., and Cohen, J. 1999. Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol. Microbiol. 33: 778-790.
17. Sun, H., Ringdahl, U., Homeister, J.W., Fay, W.P., Engleberg, N.C., Yang, A.Y., Rozek, L.S., Wang, X., Sjobring, U., and Ginsburg, D. 2004. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 305: 1283-1286.
18. Wessels, M.R., Rubens, C.E., Benedi, V.J, and Kasper, D.L. 1989. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. U.S.A. 86: 8983-8987.
19. Yoshida, K., Matsumoto, T., Tateda, K., Uchida, K., Tsujimoto, S., and Yamaguchi, K. 2000. Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae. J. Med. Microbiol. 49: 1003-1010.
20. Yoshida, S., Ogawa, M., and Mizuguchi, Y. 1985. Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect. Immun. 47: 446-451.